Health policy for sickle cell disease in Africa: experience from Tanzania on interventions to reduce under-five mortality

Julie Makani, Deogratias Soka, Stella Rwezaula, Marlene Krag, Janneth Mghamba, Kaushik Ramaiya, Sharon E Cox, Scott D Grosse, Julie Makani, Deogratias Soka, Stella Rwezaula, Marlene Krag, Janneth Mghamba, Kaushik Ramaiya, Sharon E Cox, Scott D Grosse

Abstract

Tanzania has made considerable progress towards reducing childhood mortality, achieving a 57% decrease between 1980 and 2011. This epidemiological transition will cause a reduction in the contribution of infectious diseases to childhood mortality and increase in contribution from non-communicable diseases (NCDs). Haemoglobinopathies are amongst the most common childhood NCDs, with sickle cell disease (SCD) being the commonest haemoglobinopathy in Africa. In Tanzania, 10,313 children with SCD under 5 years of age (U5) are estimated to die every year, contributing an estimated 7% of overall deaths in U5 children. Key policies that governments in Africa are able to implement would reduce mortality in SCD, focusing on newborn screening and comprehensive SCD care programmes. Such programmes would ensure that interventions such as prevention of infections using penicillin plus prompt diagnosis and treatment of complications are provided to all individuals with SCD.

Keywords: Africa; Afrique; anemia falciforme; childhood mortality; cribado de neonatos; drépanocytose; dépistage néonatal; health policy; morbidity; morbidité; morbilidad; mortalidad; mortalidad infantil; mortality; mortalité; mortalité infantile; newborn screening; pneumococcal vaccines; politique de santé; política sanitaria; public health; salud pública; santé publique; sickle cell anaemia; tendances; tendencias; trends; vaccins contre le pneumocoque; vacunas neumocócicas; África.

© 2014 The Authors. Tropical Medicine & International Health Published by John Wiley & Sons Ltd.

References

    1. Akinyanju OO, Otaigbe AI, Ibidapo MO. Outcome of holistic care in Nigerian patients with sickle cell anaemia. Clinical and Laboratory Haematology. 2005;27:195–199.
    1. Grosse SD, Atrash HK, Odame I, Amendah D, Piel FB, Williams TN. The Jamaican historical experience of the impact of educational interventions on sickle cell disease child mortality. American Journal of Preventive Medicine. 2012;42:e101–e103.
    1. Hill K, You D, Inoue M, Oestergaard MZ. Child mortality estimation: accelerated progress in reducing global child mortality, 1990–2010. PLoS Medicine. 2012;9:e1001303.
    1. Makani J, Komba AN, Cox SE, et al. Malaria in patients with sickle cell anemia: burden, risk factors, and outcome at the outpatient clinic and during hospitalization. Blood. 2010;115:215–220.
    1. Makani J, Cox SE, Soka D, et al. Mortality in sickle cell anemia in Africa: a prospective cohort study in Tanzania. PLoS One. 2011;6:e14699.
    1. Ministry of Health and Social welfare Tanzania. National Strategy for Non-Communicable Diseases 2009–2015. Division of preventative health services, Ministry of Health and Social welfare, Government of the United Republic of Tanzania; 2009.
    1. Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bulletin of the World Health Organization. 2008;86:480–487.
    1. Piel FB, Patil AP, Howes RE, et al. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet. 2013a;381:142–151.
    1. Piel FB, Hay SI, Gupta S, Weatherall DJ, Williams TN. Global burden of sickle cell anaemia in children under five, 2010–2050: modelling based on demographics, excess mortality, and interventions. PLoS Medicine. 2013b;10:e1001484.
    1. Quinn CT, Rogers ZR, Buchanan GR. Survival of children with sickle cell disease. Blood. 2004;103:4023–4027.
    1. Quinn CT, Rogers ZR, McCavit TL, Buchanan GR. Improved survival of children and adolescents with sickle cell disease. Blood. 2010;115:3447–3452.
    1. Rahimy MC, Gangbo A, Ahouignan G, et al. Effect of a comprehensive clinical care program on disease course in severely ill children with sickle cell anemia in a sub-Saharan African setting. Blood. 2003;102:834–838.
    1. Telfer P, Coen P, Chakravorty S, et al. Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London. Haematologica. 2007;92:905–912.
    1. Tshilolo L, Aissi LM, Lukusa D, et al. Neonatal screening for sickle cell anaemia in the Democratic Republic of the Congo: experience from a pioneer project on 31 204 newborns. Journal of Clinical Pathology. 2009;62:35–38.
    1. Vichinsky EP. Comprehensive care in sickle cell disease: its impact on morbidity and mortality. Seminars in Hematology. 1991;28:220–226.
    1. Weatherall D, Akinyanju O, Fucharoen S, Olivieri N, Musgrove P. Inherited disorders of hemoglobin. In: Jamison D, editor. Disease Control Priorities in Developing Countries. 2nd edn. New York: Oxford University Press; 2006. pp. 663–680.
    1. Williams TN, Uyoga S, Macharia A, et al. Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case-control study. Lancet. 2009;374:1364–1370.
    1. World Health Organization. Management of Birth Defects and Haemoglobin Disorders: Report of a Joint WHO-March of Dimes Meeting. Geneva: World Health Organisation; 2006a. [17–19 May 2006]. Report No.
    1. World Health Organization, editor. Sickle Cell Anaemia. Geneva: World Health Organisation; 2006b. [27 May 2006]. Agenda item 11.4. 59th World Health Assembly.
    1. Yanni E, Grosse SD, Yang Q, Olney RS. Trends in pediatric sickle cell disease-related mortality in the United States, 1983–2002. Journal of Pediatrics. 2009;154:541–545.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere